ArticlePeerJ2025
The platelet and coagulation function parameters in late pregnancy are associated with preeclampsia and its severity: a single-center retrospective study.
Article in PeerJ, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Second-Trimester Fibrinogen-to-Albumin Ratio and Platelet Activation Markers Compared with the HALP Score for Predicting Preeclampsia.Diagnostics (Basel, Switzerland) · 2026Article
- Homocysteine combined with multi-index screening for pregnancy complications: a narrative review.Frontiers in endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to explore the correlation between platelet and coagulation function during late pregnancy with preeclampsia (PE) as well as its severity, and concurrently establish an effective risk model to predict PE. Methods: As a retrospective case-control study, this research encompassed a sample of 594 patients of late pregnancy in Hangzhou Women's Hospital from January 2021 to April 2024, including 198 cases diagnosed with mild-PE, 198 with severe-PE, and 198 healthy pregnant women. Utilizing both univariate and multivariate analysis, this study conducted a comparison of demographic and laboratory data among these groups to uncover the correlation between platelet parameters, coagulation function, and PE as well as the severity. Ultimately, a receiver operating characteristic (ROC) curve was drawn to evaluate the predictive power of the risk model for PE. Results: Univariate analysis revealed statistically significant differences in platelet count (PC), mean platelet volume (MPV), plateletcrit (PCT), thrombin time (TT), and fibrinogen mean (FIB). Multivariate analysis showed that MPV (adjusted odds ratio (AOR) = 1.882 for mild-PE group and AOR = 2.141 for severe-PE group) and TT (AOR = 3.071 for mild-PE group and AOR = 4.154 for severe-PE group) were associated with PE. The area under curve (AUC) of the risk model of MPV combined with TT, as depicted by the ROC curve, amounted to 0.827, exhibiting a sensitivity of 0.657 and a specificity of 0.879. Conclusions: MPV and TT are independent risk factors for PE and are associated with its severity. The risk model consisting of MPV and TT possesses a certain predictive capability for PE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.